Venkatesan Jay 4
4 · Serina Therapeutics, Inc. · Filed Apr 10, 2025
Insider Transaction Report
Form 4
Venkatesan Jay
Director
Transactions
- Award
Series A Convertible Preferred Stock
2025-04-08$5.18/sh+96,525$500,000→ 96,525 total(indirect: By Trust)Exercise: $5.18From: 2025-04-08→ Common Stock, $0.0001 par value (96,525 underlying)
Footnotes (1)
- [F1]The Series A Convertible Preferred Stock is perpetual and therefore has no expiration date.